Everand Logo

Welcome to Everand!

  • Beijing Review

    MEDICAL SHIELDS

    May 07, 2020 4 minutes
    By Yuan Yuan
    Copyedited by Rebeca Toledo

    A drug approved for Chinese market last year as an antibiotic was unexpectedly found to be quite effective in treating patients with the novel coronavirus disease (COVID-19).

    Known as Carrimycin, it was independently developed by Chinese researchers over a lengthy period of 30 years. Developed for upper respiratory infections, it is the world’s first antibiotic created using synthetic biology that can be used in clinical treatment. It is also classified as a Class 1 new drug, which means it is an innovative medicine containing new chemical substances with clinical value that have never been marketed before.

    Made in

    You’re reading a preview, subscribe to read more.

    More from Beijing Review

    Beijing Review3 min readWorld
    The Trappings of Fate?
    According to the ancient Greek version of the world map from the fifth century B.C., the outermost layer of the world was ocean, and in the center of the ocean was one large continent. In the middle of the continent, there was the Mediterranean Sea.
    Beijing Review3 min readInternational Relations
    Service For A Better World
    ‘What do you want to be when you grow up?” “We children in Palestine do not grow up.” This snippet comes from a conversation between a reporter and a child in the wartorn Palestinian enclave that is the Gaza Strip in 2023. Even today, the agonies of
    Beijing Review1 min readWorld
    Strategic Support
    Chinese President Xi Jinping, also General Secretary of the Communist Party of China Central Committee and Chairman of the Central Military Commission (CMC), presents a flag to the information support force of the Chinese People’s Liberation Army (PL

    Related Books & Audiobooks